Live Breaking News & Updates on Transatlantic Inter Society Consensus

Royal Philips
Two-year data from the TOBA II BTK clinical trial demonstrate durability of dissection repair below the knee with the Philips Tack Endovascular System
Two-year data from the TOBA II BTK clinical trial demonstrate durability of dissection repair below the knee with the Philips Tack Endovascular System
June 3, 2021
has
a
Amsterdam, the Netherlands –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced positive two-year results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial. The data show the Philips Tack Endovascular System (4F), a first-of-its kind dissection repair device, provides a sustained treatment effect and positive impact on quality of life for Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI) patients at two years. The data was presented by Co-Principal Investigator George Adams, MD, Interventional Cardiologist at Rex Hospital affil ....

United States , Noord Holland , Coll Cardiol , George Adams , Chris Landon , American Association Of Cardiovascular , Society For Vascular Medicine , Society Consensus , Society For Vascular Nursing , Society For Cardiovascular Angiography , Vascular Disease Foundation , University Of North Carolina At Chapel Hill , Philips Global Press Office , Blood Institute , Society Of Interventional Radiology , National Heart , Philips Tack Endovascular , Tack Optimized Balloon Angioplasty , Philips Tack Endovascular System , Peripheral Artery Disease , Critical Limb Ischemia , Co Principal Investigator George Adams , Interventional Cardiologist , Rex Hospital , North Carolina , Chapel Hill ,